Quality of Life Among Children With Sickle Cell Disease Receiving Chronic Transfusion Therapy
- 1 July 2004
- journal article
- research article
- Published by SAGE Publications in Journal of Pediatric Oncology Nursing
- Vol. 21 (4) , 207-213
Abstract
Sickle cell disease (SCD) is a genetic disorder that is most prevalent among those of African American and Mediterranean descent. Hemoglobin SS is the most severe form of SCD and carries an increased risk for stroke. Although the initial treatment for stroke is an exchange transfusion, the use of routine, chronic transfusion therapy (CTT) has been shown to help prevent this neurological injury. The treatment plan is rigorous and time consuming, both of which impact one’s quality of life (QoL). The purpose of this study was to explore QoL, from the child’s perspective, as it is affected by CTT. Semistructured interviews were performed on 10 children undergoing CTT. Five themes emerged from the data: (a) pain, (b) school issues, (c) disease knowledge, (d) transfusion therapy, and (e) having a stroke. Data from this study reveal that CTT does have an impact on QoL. This information is important to share with those making CTT treatment decisions.Keywords
This publication has 6 references indexed in Scilit:
- Parental Report of Health-Related Quality of Life in Children with Sickle Cell DiseaseJournal of Behavioral Medicine, 2002
- Health Supervision for Children with Sickle Cell DiseasePediatrics, 2002
- A review of measures of quality of life for children with chronic illnessArchives of Disease in Childhood, 2001
- Lessons From the Stroke Prevention Trial in Sickle Cell Anemia (STOP) StudyJournal of Child Neurology, 2000
- Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler UltrasonographyNew England Journal of Medicine, 1998
- Nursing management of children with sickle cell disease: An updateJournal of Pediatric Nursing, 1995